Kraig Biocraft Laboratories Announces Highly Favorable Testing Results for Its Big Red Spider Silk Fiber
September 10 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, today
announced that the Company's initial testing of its recombinant
spider silk, Big Red, indicate that the Company's new recombinant
fiber is stronger than Monster Silk®. The testing indicates that
Big Red's strength, as measured by the ultimate load it can
withstand before breaking, is approaching that of natural spider
silk.
"These initial testing results appear to confirm the
effectiveness of our design approach with Big Red," said Company
founder and CEO, Kim K. Thompson. "Big Red was designed to be
even stronger than our breakthrough product, Monster Silk®,"
continued Thompson. "If the follow on testing confirms these
results, Big Red will be a significant breakthrough for our Company
and for material science."
"So far, Big Red has met or exceeded our expectations and design
parameters. Our plan is for Big Red to follow Monster Silk® in
our commercialization ramp up."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Sep 2023 to Sep 2024